Interleukin 6 Blockade as Steroid-sparing Treatment for 2 Patients with Giant Cell Arteritis

被引：51
|
作者：
Sciascia, Savino [1 ]
Rossi, Daniela [1 ]
Roccatello, Dario [1 ]
机构：
[1] Univ Turin, Ctr Ric Immunopatol & Documentaz Malatti Rare CMI, Dipartimento Malattie Rare Immunol Ematol & Immun, Direz Univ Immunol Clin Osped, I-10154 Turin, Italy
来源：
JOURNAL OF RHEUMATOLOGY | 2011年 / 38卷 / 09期
关键词：
PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; METHOTREXATE; ARTHRITIS;
D O I：
10.3899/jrheum.110496
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2080 / 2082
页数：3
相关论文
共 50 条
  • [1] No additional steroid-sparing effect of cyclosporine A in giant cell arteritis
    Schaufelberger, C.
    Mollby, H.
    Uddhammar, A.
    Bratt, J.
    Nordborg, E.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 (04) : 327 - 329
  • [2] No additional steroid-sparing effect of cyclosporin A in patients with Giant Cell Arteritis.
    Schaufelberger, C
    Mölby, H
    Bratt, J
    Nordborg, E
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S268 - S268
  • [3] Mycophenolate mofetil as steroid-sparing treatment for elderly patients with giant cell arteritis: report of three cases
    Sciascia, Savino
    Piras, Doloretta
    Baldovino, Simone
    Russo, Alessandra
    Naretto, Carla
    Rossi, Daniela
    Alpa, Mirella
    Roccatello, Dario
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 24 (03) : 273 - 277
  • [4] Mycophenolate mofetil as steroid-sparing treatment for elderly patients with giant cell arteritis: report of three cases
    Savino Sciascia
    Doloretta Piras
    Simone Baldovino
    Alessandra Russo
    Carla Naretto
    Daniela Rossi
    Mirella Alpa
    Dario Roccatello
    Aging Clinical and Experimental Research, 2012, 24 : 273 - 277
  • [5] OUTCOMES OF PATIENTS TREATED WITH TOCILIZUMAB OR ABATACEPT AS STEROID-SPARING AGENTS WITH GIANT CELL ARTERITIS
    Rossi, Daniela
    Cecchi, Irene
    Rubini, Elena
    Radin, Massimo
    Sciascia, Savino
    Roccatello, Dario
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 436 - 436
  • [6] CLINICAL AND SEROLOGICAL OUTCOMES OF PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB OR ABATACEPT AS STEROID-SPARING AGENTS
    Rossi, D.
    Cecchi, I.
    Rubini, E.
    Radin, M.
    Sciascia, S.
    Roccatello, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1477 - 1477
  • [7] Clinical and Serological Outcomes of Patients with Giant Cell Arteritis Treated with Tocilizumab or Abatacept As Steroid-Sparing Agents
    Rossi, Daniela
    Cecchi, Irene
    Rubini, Elena
    Raclin, Massimo
    Sciascia, Savino
    Roccatello, Dario
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [8] Steroid-sparing effect and toxicity of dapsone treatment in giant cell arteritis A single-center, retrospective study of 70 patients
    Ly, Kim Heang
    Dalmay, Francois
    Gondran, Guillaume
    Palat, Sylvain
    Bezanahary, Holy
    Cypierre, Anne
    Fauchais, Anne-Laure
    Liozon, Eric
    MEDICINE, 2016, 95 (42)
  • [9] Efficacy of leflunomide as a steroid-sparing agent in treatment of Indian giant cell arteritis patients: A 2-year follow-up study
    Das, Shyamashis
    Goswami, Rudra Prosad
    Sinha, Debanjali
    Ghosal, Anirban
    Datta, Ashis
    Sarkar, Sanjukta
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2022, 25 (06) : 650 - 658
  • [10] Minocycline has a steroid-sparing effect in treatment of takayasu arteritis
    Matsuyama, A
    Sakai, N
    Ishigami, M
    Kashine, S
    Hirata, A
    Nakamura, T
    Hiraoka, H
    Yamashita, S
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 136 - 136
12345